Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | RRM1 | P23921 | 1/20 | 0.54 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MPI | P34949 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304032 | 1.00 | ERN1 (1.00) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL11520332 | 0.98 | ERN1 (0.96) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL11407376 | 0.98 | ERN1 (0.96) | ERN1KDM4EHTTNPC1MAPT | |
| Hydrazine SCHEMBL28732767 | 0.96 | ERN1 (0.92) | ERN1KDM4EHTTNPC1MAPT | |
| Phenol SCHEMBL2787265 | 0.93 | ERN1 (0.86) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL10615396 | 0.90 | ERN1 (0.82) | ERN1KDM4EHTTNPC1MAPT | |
| Orthocresol SCHEMBL2131451 | 0.88 | ERN1 (0.77) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL5823063 | 0.85 | KDM4E (0.73) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL249731 | 0.83 | ERN1 (0.71) | ERN1KDM4EHTTNPC1MAPT | |
| SCHEMBL7915285 | 0.83 | ERN1 (0.70) | ERN1KDM4EHTTNPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069594-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | INST NAT SANTE RECH MED (FR) | 2026-03-12 | — | — | US | claimed |
| EP-4580611-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-09 | — | — | EP | claimed |
| EP-4534266-A1 | CHEMICAL MODIFICATION OF WOOD TO IMPROVE LIGHT FASTNESS | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2025-04-09 | — | — | EP | claimed |
| WO-2024047196-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-03-07 | — | — | WO | claimed |
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | HENKEL AG & CO. KGAA (DE) | 2024-03-05 | — | — | US | claimed |
| US-20220184083-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2022-06-16 | — | — | US | claimed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | claimed |
| EP-3941448-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-01-26 | — | — | EP | claimed |
| US-20260069594-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | INST NAT SANTE RECH MED (FR) | 2026-03-12 | — | — | US | disclosed |
| EP-4580611-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-09 | — | — | EP | disclosed |
| EP-4534266-A1 | CHEMICAL MODIFICATION OF WOOD TO IMPROVE LIGHT FASTNESS | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2025-04-09 | — | — | EP | disclosed |
| CN-112955141-B | Improved method for inducing tissue regeneration and senescent cell lysis in mammalian cells | AGEX治疗公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4423055-A1 | SPERMINE DERIVATIVES AS HEPARIN ANTIDOTES | Consejo Superior de Investigaciones Cientificas (ES) | 2024-09-04 | — | — | EP | disclosed |
| US-11939691-B2 | Tin or tin alloy electroplating bath, and electronic component having electrodeposit formed thereon using the plating bath | ISHIHARA CHEMICAL CO., LTD. (JP) | 2024-03-26 | — | — | US | disclosed |
| US-20220184083-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2022-06-16 | — | — | US | disclosed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | disclosed |
| WO-2022104222-A1 | AROMATIC DIOL COMPOUNDS, DIEPOXIDE COMPOUNDS, POLYMERS PREPARED FROM SUCH COMPOUNDS, AND METHODS FOR MAKING THE SAME | SWIMC LLC (US) | 2022-05-19 | — | — | WO | disclosed |
| CN-114456279-A | Preparation method of chitosan hydroxy naphthalene aldehyde Schiff base and chitosan hydroxy naphthalene aldehyde Schiff base copper complex, and product and application thereof | 西南林业大学 | 2022-05-10 | — | — | CN | disclosed |
| WO-2022070946-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT | 東レ株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2022043496-A2 | USE OF MAIT CELLS AS BIOMARKERS AND BIOTARGETS IN COVID-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | TYR, HAO2, HAAO | ERN1 4459/4885KDM4E 1526/4885HTT 791/4885 |
| US-20260069594-A1 | USE OF AN AGENT CAPABLE OF INHIBITING THE ACTIVATION OF MAIT CELLS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | MIF, MTX1, PTGS1 | ERN1 4655/4885KDM4E 2194/4885HTT 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.